相关实验视频

Updated: Jul 9, 2025

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.8K

需要多少语音数据来跟踪阿尔茨海默病中的语言变化? 随机长度,5分钟和1分钟自发语音样本的比较

Ulla Petti1, Simon Baker1, Anna Korhonen1

  • 1Language Technology Lab, University of Cambridge, Cambridge, UK.

Digital biomarkers
|November 29, 2023
PubMed
概括

针对阿尔茨海默病 (AD) 的语音分析从特定样本长度中受益. 一个5分钟的语音样本可靠地追踪认知衰退,这表明更长的录音为AD生物标志物提供了有价值的数据.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.痴呆症是一种痴呆症.数字生物标志物数字生物标志物数字健康数字健康语言 语言 语言 语言自然语言处理自然语言处理.演讲 演讲 演讲

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment06:48

Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment

Published on: June 25, 2019

9.2K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195